<!doctype html><html lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><title>Truepill taps Sid Viswanathan as next CEO and other digital health hires | ZoomVlog</title><meta name=generator content="Hugo 0.98.0"><meta name=description content="Truepill has tapped Sid Viswanathan as its next CEO. This news comes after the digital pharmacy announced a $142 million funding deal in October. 
A cofounder of the company, Viswanathan started Truepill in 2016. Since then he served as the company’s president. In this new position, he will handle day-to-day operations. He is taking over for fellow cofounder Umar Afridi, who will continue to have involvement with the company as a member of the board of directors."><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/normalize.css><link href="https://fonts.googleapis.com/css?family=Open+Sans:400,700" rel=stylesheet type=text/css><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/cayman.css><link rel=apple-touch-icon sizes=180x180 href=./apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=./favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=./favicon-16x16.png><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.css integrity=sha384-yFRtMMDnQtDRO8rLpMIKrtPCD5jdktao2TV19YiZYWMDkUR5GQZR/NOVTdquEx1j crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.js integrity=sha384-9Nhn55MVVN0/4OFx7EE5kpFBPsEMZxKTCnA+4fqDmg12eCTqGi6+BB2LjY8brQxJ crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body)></script></head><body><section class=page-header><h1 class=project-name>ZoomVlog</h1><h2 class=project-tagline></h2><nav><a href=./index.html class=btn>Blog</a>
<a href=./sitemap.xml class=btn>Sitemap</a>
<a href=./index.xml class=btn>RSS</a></nav></section><section class=main-content><h1>Truepill taps Sid Viswanathan as next CEO and other digital health hires</h1><div><strong>Publish date: </strong>2024-06-30</div><img src=https://cdn.statically.io/img/247newsaroundtheworld.com/wp-content/uploads/2022/03/hires-Hero-Images-Inc._0.jpg style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268><strong>Truepill </strong>has tapped <strong>Sid Viswanathan </strong>as its next CEO. This news comes after the digital pharmacy announced a </span>$142 million funding deal in October.&nbsp;</p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>A cofounder of the company, Viswanathan started Truepill in 2016. Since then he served as the company’s president. In this new position, he will handle&nbsp;day-to-day operations. He is taking over for fellow cofounder Umar Afridi, who will continue to have involvement with the company as a member of the board of directors.</span></p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>Previously </span>Viswanathan served in Johnson & Johnson’s Global Operations Leadership Development program and founded CardMunch.</p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>“From the very beginning, our vision has been to create a world where healthcare is accessible and convenient for everyone,”&nbsp;Viswanathan said in a statement. “I’m honored to continue deepening Truepill’s work, partnering with industry leading organizations to create solutions that raise the bar for consumer expectations and empower everyone with access to the care they deserve.”</span></p><p dir=ltr><span><strong>Dr. Jay Bhatt </strong>was named the executive director of the <strong>Deloitte Center for Health Solutions and the Deloitte Health Equity Institute</strong>. Bhatt is coming from the American Hospital Association, where he served as the senior vice president and chief medical officer.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>Previously Bhatt was on the Northwestern Medicine faculty and served as the chief health officer at the Illinois Health and Hospital Association.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>“Growing up, I had a front-row seat to the challenges that many people face in disadvantaged communities, and these early life experiences convinced me not just to become a doctor, but to become someone who could meet the challenge of treating diverse populations, serving underserved neighborhoods, and helping communities and organizations change their future,”&nbsp;Bhatt said in a statement.</span></p><p dir=ltr><span>“I am excited to join an organization with a strong legacy of progress, execution and impact, and one with a mission that reflects my values and aspirations to transform the health of our communities and do it at scale.”</span></p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>French artificial intelligence company <strong>Owkin</strong> named <strong>Dr. Vassili Soumelis</strong> as its next chief medical officer and <strong>Eric Durand</strong> as its SVP of data science. Soumelis is a professor at Université de Paris, coordinator of ImmunAID and a practicing physician.&nbsp;</span></p><p><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>Durand is coming to Owkin after serving as director of data science at Novartis. His new duties will include overseeing data science activities at the company.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-df19164c-7fff-977e-b8bf-cfde9d729268>“I was struck early on by the quality and the innovative nature of Owkin’s work,” Durand&nbsp;said in a statement. “Combined with the incredible data asset the company is building through its federated platform, I believe Owkin is uniquely positioned to make a lasting impact on patients.</span></p><p dir=ltr><span>“Helping to bring the best analytics to impact drug discovery has been my goal for many years, and it is hard for me to imagine a better place than Owkin for furthering this mission. I can’t wait to get started.”</span></p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmhqZGy7psPSmqmorZ6Zwamx1qippZxemLyue8eemKWsmGK7psPSaKurrZWltq24jK2YqatdqLaledWiqrCZnpbBqa3NZpisZZ6axbV5wp6mZpmemXqwwMeeqWacmZy2ta3LZp%2BemZyptW60yKucrGc%3D</p><footer class=site-footer><span class=site-footer-credits>Made with <a href=https://gohugo.io/>Hugo</a>. © 2022. All rights reserved.</span></footer></section><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/banner.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>